Cilostazol

Overview

Cilostazol (OPC 13013) is a potent and selective inhibitor of phosphodiesterase (PDE) 3A , the isoform of PDE 3 in the cardiovascular system, with an IC 50 of 0.2 μM.

Application

Products | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Digestive System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Autophagy | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Phosphodiesterase (PDE) | Products > Signaling Pathways > Autophagy

Product Information

• Catalog No.: HY-17464
• CAS No.: 73963-72-1
• Molecular Formula: C20H27N5O2
• Molecular Weight: 369.46
• Purity: 99.77%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: 2 mg/mL (5.41 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source